BDBM618074 5-(1-(4-(5-(difluoromethyl)-1,3,4-oxadiazol-2-yl)-2,3-difluorobenzyl)-1H-1,2,3-triazol-4-yl)pyridin-2-amine::US20230286970, Compound 21::US20230286970, Compound 385

SMILES Nc1ccc(cn1)-c1cn(Cc2ccc(-c3nnc(o3)C(F)F)c(F)c2F)nn1

InChI Key InChIKey=VWMYIUMAPMTYHC-UHFFFAOYSA-N

Data  13 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 13 hits for monomerid = 618074   

TargetHistone deacetylase 6(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 17nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 6(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 30nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 9(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetPolyamine deacetylase HDAC10(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 11(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 3(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 4(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 5(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 7(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 2(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 3.00E+4nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 8(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 2.00E+5nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 2.00E+5nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent

TargetHistone deacetylase 1(Human)
Italfarmaco

US Patent
LigandPNGBDBM618074(US20230286970, Compound 21 | US20230286970, Compou...)
Affinity DataIC50: 1.00E+6nMAssay Description:For each test compound, 100× concentrated DMSO solutions at 8 doses were prepared and then diluted in assay buffer (25 mM Tris-HCl, pH 8, 130 mM NaCl...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/23/2023
Entry Details
US Patent